Clinical Trial Update: Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy

View source ↗

Summary

This clinical trial update evaluates whether the sphingolipid metabolite S1P can serve as a biomarker for food allergy and related anaphylaxis; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Food Allergy

Snippet

Sponsor: Medical University of Vienna | Conditions: Food Allergy, Anaphylaxis | Status: UNKNOWN